Nephros (NEPH) Research & Development (2010 - 2026)
Nephros (NEPH) posted quarterly Research & Development of $346000.0 for Q1 2026, up 17.29% year-over-year from $295000.0 in Q1 2025, and down 12.41% quarter-over-quarter from $395000.0 in Q4 2025.
Nephros (NEPH) Research & Development (2010 - 2026) Analysis & Trends
Nephros' Research & Development history runs 17 years deep, the most recent figure standing at $346000.0 for Q1 2026.
- In Q1 2026, Research & Development rose 17.29% year-over-year to $346000.0; the TTM figure through Mar 2026 stood at $1.4 million (up 40.55% YoY), while the FY2025 annual figure was $1.3 million, up 47.79% from the prior year.
- Research & Development for Q1 2026 stood at $346000.0, down from $395000.0 in the prior quarter.
- The five-year high for Research & Development was $395000.0 in Q4 2025, with the low at $188000.0 in Q3 2024.
- The 5-year median for Research & Development is $254000.0 (2024), against an average of $277647.1.
- The sharpest annual moves came in 2022 and 2025: Research & Development sank 43.94% in 2022, then jumped 79.79% in 2025.
- Nephros' Research & Development stood at $359000.0 in 2022, then sank by 42.06% to $208000.0 in 2023, then increased by 21.15% to $252000.0 in 2024, then jumped by 56.75% to $395000.0 in 2025, then declined by 12.41% to $346000.0 in 2026.
- Business Quant data shows NEPH's Research & Development at $346000.0 in Q1 2026, $395000.0 in Q4 2025, and $338000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 370.60 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 258.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 663.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 105.73 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 178.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 42.50 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 129.00 Mn |
| 10 | Nephros | 48.26 Mn | 43.56 Mn | 4.03 Mn | 366,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 366,000.00 |
| Mar 31, 2026 | 346,000.00 |
| Dec 31, 2025 | 395,000.00 |
| Sep 30, 2025 | 338,000.00 |
| Jun 30, 2025 | 311,000.00 |
| Mar 31, 2025 | 295,000.00 |
| Dec 31, 2024 | 252,000.00 |
| Sep 30, 2024 | 188,000.00 |
| Jun 30, 2024 | 254,000.00 |
| Mar 31, 2024 | 212,000.00 |
| Dec 31, 2023 | 208,000.00 |
| Sep 30, 2023 | 205,000.00 |
| Jun 30, 2023 | 221,000.00 |
| Mar 31, 2023 | 239,000.00 |
| Dec 31, 2022 | 359,000.00 |
| Sep 30, 2022 | 252,000.00 |
| Jun 30, 2022 | 273,000.00 |
| Mar 31, 2022 | 372,000.00 |
| Dec 31, 2021 | 328,000.00 |
| Sep 30, 2021 | 395,000.00 |